Altered expression of insulin-like growth factor II receptor in human pancreatic cancer

Pancreas

Volumn 15, Issue 4, 1997, Pages 367-373

  Ishiwata, Toshiyuki ^a   Bergmann, Uwe ^a   Kornmann, Marko ^a   Lopez, Martha ^a   Beger, Hans G ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Altered expression; Human pancreatic cancer; Insulin like growth factor II receptor

Indexed keywords

MESSENGER RNA; SOMATOMEDIN B RECEPTOR;

ACINAR CELL; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PANCREAS CANCER; PANCREAS DUCT; PANCREAS ISLET CELL; PRIORITY JOURNAL;

EID: 0030816910     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199711000-00006     Document Type: Article

References (39)

1. Silverberg E, Lubera JA. Cancer statistics. Cancer J Clin 1989;3: 3-39.
2. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284-303.
3. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
4. Casey G, Yamanaka Y, Friess H, et al. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 1992;69:151-60.
5. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
6. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90:1352-60.
7. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007-11.
8. Kobrin MS, Yamanaka Y, Friess H, Lopez ME, Korc M. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993;53:4741-4.
9. Friess H, Yamanaka Y, Buchler M, et al. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-56.
10. Ebert M, Yokoyama M, Friess H, Buchler MW, Korc M. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994;54:5775-8.
11. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 1995;55:1129-38.
12. Eben M, Yokoyama M, Friess H, Kobrin MS, Buchler MW, Korc M. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer 1995;62:529-35.
13. Baldwin RL, Friess H, Yokoyama M, et al. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 1996;67:283-8.
14. Bergmann U, Funatomi H, Kornmann M, Ishiwata T, Beger HG, Korc M. Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1: in vivo evidence for an islet-cancer cell axis. Int J Oncol 1996;9:487-92.
15. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 1989;10:68-91.
16. Czech MP. Signal transmission by the insulin-like growth factors. Cell 1989;59:235-8.
17. Minniti CP, Kohn EC, Grubb JH, et al. The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J Biol Chem 1992;267:9000-4.
18. El-Roeiy, Chen X, Roberts VJ, et al. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metabol 1994;78:1488-96.
19. Hermanek P, Sobin LH. TNM classification of malignant tumours. In: UICC, International Union Against Cancer. New York: Springer Verlag, 1987:65-8.
20. Kiess W, Haskell JF, Lee L, et al. An antibody that blocks insulin-like growth factor (IGF-I) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. J Biol Chem 1987;262:12745-51.
21. Chomczynski P, Sacchi N. Single-step RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
22. Adams MD, Dubnick M, Kerlavage AR, et al. Sequence identification of 2,375 human brain genes. Nature 1992;355:632-4.
23. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
24. MacDonald RG, Pfeffer SR, Coussens L, et al. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 1988;239:1134-7.
25. Kornfeld S. Structure and function of the mannose 6-phosphate/ insulin-like growth factor II receptor. Annu Rev Biochem 1992;61: 307-30.
26. Frosch RG, Busby WH, Schwander J. Actions of insulin-like growth factors. Annu Rev Physiol 1985;47:443-67.
27. Daughaday WH. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 1990;127:1-1.
28. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-20.
29. Garmroudi F, MacDonald RG. Localization of the insulin-like growth factor II (IGF-II) binding/cross-linking site of the IGF-II/ mannose 6-phosphate receptor to extracellular repeats 10-11. J Biol Chem 1994;269:26944-52.
30. Dahms NM, Rose PA, Molkentin JD, Zhang Y, Brzycki MA. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. The role of arginine residues in mannose 6-phosphate binding. J Biol Chem 1993;268:5457-63.
31. Garmroudi F, Devi G, Slentz DH, Schaffer BS, MacDonald RG. Truncated forms of the insulin-like growth factor II (IGF-II)/ mannose 6-phosphate receptor encompassing the IGF-II binding site: characterization of a point mutation that abolishes IGF-II binding. Mol Endocrinol 1996;10:642-51.
32. Nissley P, Kiess W, Sklar MM. The insulin-like growth factor II/mannose 6-phosphate receptor. In: LeRoith, ed. Insulin-like growth factors: molecular and cellular aspects. Boca Raton, FL: CRC Press, 1991:111-50.
33. Scott CD, Ballesteros M, Baxter RC. Increased expression of insulin-like growth factor-11/mannose-6-phosphate receptor in regenerating rat liver. Endocrinology 1990;127:2210-6.
34. Kasper D, Dittmer F, von Figura K, Pohlmann R. Neither type of mannose 6-phosphate receptor is sufficient for targeting of lysosomal enzymes along intracellular routes. J Cell Biol 1996;134: 615-23.
35. Dahms NM, Seetharam B, Wick DA. Expression of insulin-like growth factor (IGF)-I receptors. IGF-II/cation-independent mannose 6-phosphate receptors (CI-MPRs), and cation-dependent MPRs in polarized human intestinal Caco-2 cells. Biochim Biophys Acta 1996;1279:84-92.
36. Al Kawas S, Amizuka N, Bergeron JJM, Warshawsky H. Immunolocalization of the cation-independent mannose 6-phosphate receptor and cathepsin B in the enamel organ and alveolar bone of the rat incisor. Cal Tissue Int 1996;59:192-9.
37. Jirtle RL, Haag JD, Ariazi EA, Gould MN. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors. Cancer Res 1993;53:3849-52.
38. Saperstein LA, Jirtle RL, Farouk M, Thompson HJ, Chung KS, Meyers WC. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology 1994;19:412-7.
39. Souza RF, Appel R, Yin J, et al. Microsatellite instability in the insulin-like growth factor-II receptor gene in gastrointestinal tumors. Nat Genet 1996;14:255-7.